Trial intelligence / Profile preview

Dose assessment of melatonin in sepsis trial (DAMSEL 2)

2014-002840-42Phase 2Unknown

Sponsor
University of Aberdeen
Start
Oct 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 2 trial of melatonin in sepsis and community-acquired pneumonia (CAP), sponsored by University of Aberdeen. Status: unknown.

02

Drugs

melatonin
03

Conditions

sepsiscommunity-acquired pneumonia (CAP)

Beyond the preview

Go deeper on 2014-002840-42.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2014-002840-42.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call